US Tariffs Threaten Ireland’s Pharmaceutical Industry
Proposed measures target tax practices of multinational drugmakers
The United States is preparing to impose new tariffs on Ireland, a move expected to impact the country’s lucrative pharmaceutical sector.
The measures aim to curb tax strategies used by multinational drugmakers, potentially disrupting a key driver of Ireland’s economy and raising concerns over trade relations.
The measures aim to curb tax strategies used by multinational drugmakers, potentially disrupting a key driver of Ireland’s economy and raising concerns over trade relations.
